Introduction/Aim. Microencapsulation technology can be used for the protection of Alpha-tocopherol from degradation in unfavorable environments and enhancement of bioavailability and shelf-life of vitamin E. The aim of this study was the synthesis and characterization of alginate microparticles for the oral delivery of a-tocopherol. Methods. Four different formulations of Alpha-tocopherol loaded calcium alginate microparticles for oral delivery were synthesized by external ionotropic gelation method. The vitamin E content in microparticles was 0.5%, 1% and 2% (w/w); the vitamin E/sodium alginate ratio was 1:1 and 1:2. All microparticles were characterized by average particles size, swelling degree, vitamin E content, loading capacity, and encapsulation efficiency. Results. Spherically shaped microparticles with the diameter of 500 to 1000 µm were obtained after the drying process. The size and the swelling degree did not change significantly in 0.1 M HCL, while they were increased in base conditions of phosphate buffer of pH 6.8 and 7.4. Encapsulated vitamin E content was not significantly different between formulations (0.30 ± 0.010 - 0.60 ± 0.021 mg/mL). The loading capacities were in the range between 10 ± 0.11% and 20.45 ± 0.22%, while encapsulation efficiency percentages were between 18.94 ± 0.32% and 31.91 ± 0.41%. Conclusion. The optimum conditions for Alpha-tocopherol encapsulation with the highest percentage of loading capacity and encapsulation efficacy were obtained using 1% sodium alginate, 2% calcium chloride, and vitamin E/polymer in the ratio 1:1. All four formulations showed the expected behavior in different mediums, which simulated gastrointestinal fluids in vivo (0.1 M HCL, phosphate buffer pH 6.8 and pH 7.4): gastroresistance, increasing in the size, and swelling degree in intestinal fluids. This emphasizes the use of alginate microparticles as a carrier for the oral delivery of vitamin E.
References
1.
Jana S, Kumar Sen K, Gandhi A. Alginate Based Nanocarriers for Drug Delivery Applications. Current Pharmaceutical Design. 2016;22(22):3399–410.
2.
Saez V, Souza IDL, Mansur CRE. Lipid nanoparticles (SLN & NLC) for delivery of vitamin E: a comprehensive review. International Journal of Cosmetic Science. 2018;40(2):103–16.
3.
Somchue W, Sermsri W, Shiowatana J, Siripinyanond A. Encapsulation of α-tocopherol in protein-based delivery particles. Food Research International. 2009;42(8):909–14.
4.
Strobel SA, Scher HB, Nitin N, Jeoh T. In situ cross-linking of alginate during spray-drying to microencapsulate lipids in powder. Food Hydrocolloids. 2016;58:141–9.
5.
Chuang JJ, Huang YY, Lo SH, Hsu TF, Huang WY, Huang SL, et al. Effects of pH on the Shape of Alginate Particles and Its Release Behavior. International Journal of Polymer Science. 2017;2017:1–9.
6.
G. Gómez-Mascaraque L, Martínez-Sanz M, Hogan SA, López-Rubio A, Brodkorb A. Nano- and microstructural evolution of alginate beads in simulated gastrointestinal fluids. Impact of M/G ratio, molecular weight and pH. Carbohydrate Polymers. 2019;223:115121.
7.
Hoad C, Rayment P, Cox E, Wright P, Butler M, Spiller R, et al. Investigation of alginate beads for gastro-intestinal functionality, Part 2: In vivo characterisation. Food Hydrocolloids. 2009;23(3):833–9.
8.
Čalija B, Milić J, Cekić N, Krajišnik D, Daniels R, Savić S. Chitosan oligosaccharide as prospective cross-linking agent for naproxen-loaded Ca-alginate microparticles with improved pH sensitivity. Drug Development and Industrial Pharmacy. 2013;39(1):77–88.
9.
Nagamalleswari G, Krishna KS, Abhinandana P. Estimation of tocopherol (vit-e) content in different edible oils before and after heating. Int J Pharm Res. 2019;11(3):75–8.
10.
Čalija B, Cekić N, Savić S, Krajišnik D, Daniels R, Milić J. An investigation of formulation factors affecting feasibility of alginate-chitosan microparticles for oral delivery of naproxen. Archives of Pharmacal Research. 2011;34(6):919–29.
11.
Pestovsky YS. The Synthesis of Alginate Microparticles and Nanoparticles. Drug Designing & Intellectual Properties International Journal. 3(1).
12.
Singh J, Kaur K, Kumar P. Optimizing microencapsulation of α-tocopherol with pectin and sodium alginate. Journal of Food Science and Technology. 2018;55(9):3625–31.
13.
Yoshida K, Onoe H. Functionalized core-shell hydrogel microsprings by anisotropic gelation with bevel-tip capillary. Scientific Reports. 7(1).
14.
Gurruchaga H, Saenz del Burgo L, Ciriza J, Orive G, Hernández RM, Pedraz JL. Advances in cell encapsulation technology and its application in drug delivery. Expert Opinion on Drug Delivery. 2015;12(8):1251–67.
15.
Bhujbal SV, de Vos P, Niclou SP. Drug and cell encapsulation: Alternative delivery options for the treatment of malignant brain tumors. Advanced Drug Delivery Reviews. 2014;67–68:142–53.
16.
Hariyadi DM, Islam N. Current Status of Alginate in Drug Delivery. Advances in Pharmacological and Pharmaceutical Sciences. 2020;2020:1–16.
17.
Goh CH, Heng PWS, Chan LW. Alginates as a useful natural polymer for microencapsulation and therapeutic applications. Carbohydrate Polymers. 2012;88(1):1–12.
18.
Abasalizadeh F, Moghaddam SV, Alizadeh E, akbari E, Kashani E, Fazljou SMB, et al. Alginate-based hydrogels as drug delivery vehicles in cancer treatment and their applications in wound dressing and 3D bioprinting. Journal of Biological Engineering. 2020;14(1).
19.
Trojanowska A, Giamberini M, Tsibranska I. Microencapsulation in food chemistry. J Membr Sci Res. 2017;3:265–071.
20.
Bansode SS, Banarjee SK, Gaikwad DD. Microencapsulation: a review. Int J Pharm Sci Rev Res. 2010;1:38–43.
21.
Ehterami A, Salehi M, Farzamfar S, Samadian H, Vaez A, Ghorbani S, et al. Chitosan/alginate hydrogels containing Alpha-tocopherol for wound healing in rat model. Journal of Drug Delivery Science and Technology. 2019;51:204–13.
The statements, opinions and data contained in the journal are solely those of the individual authors and contributors and not of the publisher and the editor(s). We stay neutral with regard to jurisdictional claims in published maps and institutional affiliations.
,
